跳至主要内容
临床试验/EUCTR2017-002192-25-NL
EUCTR2017-002192-25-NL进行中(未招募)1 期

eurotoxic adverse effects of morphine and oxycodone in continuous subcutaneous infusion for treatment of pain in terminal patients with diminished renal function: a Randomized Controlled Trial. - MOSART-study

Center of Expertise in Palliative Care, Maastricht University Medical Centre0 个研究点目标入组 234 人开始时间: 2017年7月26日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
234

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - minimal age of 18 years at the time of inclusion;
  • - the subject is in the terminal phase, i.e. death in the near future is expected by the treating physician;
  • - start of CSCI with an opioid for treatment of pain is indicated by the treating physician;
  • - willingness to allow one-time blood collection for assessment of renal function (eGFR);
  • - a signed informed consent is given by the participant or his/her legal representative.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 234
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 234

排除标准

  • - delirium at the time of inclusion;
  • - opioid induced hyperalgesia (OIH) at the time of inclusion;
  • - a medical necessity to apply a different opioid than morphine or oxycodone, such as previously demonstrated non-response to morphine or oxycodone (defined as a complete absence of any pain reduction after appropriate dosage), previously demonstrated unacceptable side effects of morphine or oxycodone, or a medical indication for an opioid with NMDA-receptor-antagonistic properties (currently only known for methadone);
  • - a documented allergy for morphine or oxycodone.

研究者

发起方
Center of Expertise in Palliative Care, Maastricht University Medical Centre

相似试验

Adverse effects of morphine and oxycodone for... | 临床试验